Haemonetics
296 hedge funds and large institutions have $4.3B invested in Haemonetics in 2023 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 98 increasing their positions, 111 reducing their positions, and 38 closing their positions.
281% more call options, than puts
Call options by funds: $8.4M | Put options by funds: $2.21M
3% more capital invested
Capital invested by funds: $4.19B → $4.3B (+$117M)
0.66% less ownership
Funds ownership: 100.61% → 99.95% (-0.66%)
2% less funds holding
Funds holding: 301 → 296 (-5)
11% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 38
12% less repeat investments, than reductions
Existing positions increased: 98 | Existing positions reduced: 111
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Top Buyers
| 1 |
Invesco
Atlanta,
Georgia
|
+$34.4M |
| 2 |
Morgan Stanley
New York
|
+$22.9M |
| 3 |
Franklin Resources
San Mateo,
California
|
+$18.8M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$14.5M |
| 5 |
Boston Partners
Boston,
Massachusetts
|
+$8.11M |
Top Sellers
HAE Hedge Fund Activity: Q2 2023 in Review
296 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Haemonetics (HAE) for Q2 2023, worth a combined $4.3B — up 2.8% from $4.19B a quarter earlier.
Sellers outnumbered buyers: 38 funds closed out of HAE and 34 opened new positions — a net loss of 4 holders — while 111 trimmed existing stakes and 98 added.
The largest buyer was Invesco, adding an estimated $34.4M. The largest seller was Envestnet Asset Management, cutting an estimated $32M.
- 296 institutional investors held Haemonetics (HAE) as of Q2 2023, down from 301 in Q1 2023.
- Funds reported $4.3B of Haemonetics stock for Q2 2023, up 2.8% quarter-over-quarter.
- 34 funds opened new Haemonetics positions in Q2 2023 and 38 closed out, a net change of -4 holders.
- The largest Haemonetics buyer in Q2 2023 was Invesco, an estimated $34.4M added.
- The largest Haemonetics seller in Q2 2023 was Envestnet Asset Management, an estimated $32M sold.
Based on aggregated 13F filings for Q2 2023.